Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Heijman, J; Kirchner, D; Kunze, F; Chrétien, EM; Michel-Reher, MB; Voigt, N; Knaut, M; Michel, MC; Ravens, U; Dobrev, D.
Muscarinic type-1 receptors contribute to IK,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation
INT J CARDIOL. 2018; 255: 61-68. Doi: 10.1016/j.ijcard.2017.12.050 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Leading authors Med Uni Graz
Heijman Jordi
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Background: Basal and acetylcholine-gated inward-rectifier K+-currents (I-K1 and I-K,I-ACh, respectively) are altered in atrial fibrillation (AF). G(i)-protein-coupled muscarinic (M) receptors type-2 are considered the predominant receptors activating I-K,I-ACh. Although a role for G(q)-coupled non-M-2-receptor subtypes has been suggested, the precise regulation of I-K,I-ACh by multiple M-receptor subtypes in the human atrium is unknown. Here, we investigated M-1-receptor-mediated I-K,I-ACh regulation and its remodeling in chronic AF (cAF). Methods and results: M-1-receptor mRNA and protein abundance were increased in atrial cardiomyocyte fractions and atrial homogenates from cAF patients, whereas M-2-receptor levels were unchanged. The regulation of I-K,I-ACh by M-1-receptors was investigated in right-atrial cardiomyocytes using two applications of the M-receptor agonist carbachol (CCh, 2 mu M), with pharmacological interventions during the second application. CCh application produced a rapid current increase (Peak-I-K,I-ACh), which declined to a quasi-steady-state level (Qss-I-K,I-ACh). In sinus rhythm (Ctl) the selective M-1-receptor antagonists pirenzepine (10 nM) and muscarinic toxin-7 (MT-7, 10 nM) significantly inhibited CCh-activated Peak-IK, ACh, whereas in cAF they significantly reduced both Peak- and Qss-I-K,I-ACh, with no effects on basal inward-rectifier currents in either group. Conversely, the selective M-1-receptor agonist McN-A-343 (100 mu M) induced a current similar to the CCh-activated current in Ctl atrial cardiomyocytes pretreated with pertussis toxin to inhibit M-2-receptor-mediated G(i)-protein signaling, which was abolished by MT-7. Computational modeling indicated that M-1- and M-2-receptors redundantly activate I-K,I-ACh to abbreviate APD, albeit with predominant effects of M-2-receptors. Conclusion: Our data suggest that G(q)-coupledM(1)-receptors also regulate human atrial I-K,I-ACh and that their relative contribution to I-K,I-ACh activation is increased in cAF patients. We provide novel insights about the role of non-M-2-receptors in human atrial cardiomyocytes, which may have important implications for understanding AF pathophysiology. (c) 2017 Elsevier B.V. All rights reserved.

Find related publications in this database (Keywords)
Atrial fibrillation
Inward-rectifier K+-channel
Muscarinic receptor subtypes
© Med Uni GrazImprint